Form 4 Filing for Apogee Therapeutics, Inc. - Officer Transaction

This filing details a transaction by Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics, Inc. On June 22, 2026, Mr. Dambkowski disposed of 26,400 shares of Common Stock. The shares were sold at a weighted average price of $132.60, with individual transactions ranging from $132.55 to $132.645. This sale was executed under a Rule 10b5-1 trading plan adopted on September 22, 2025. Following this transaction, Mr. Dambkowski holds 179,248 shares of Apogee Therapeutics, Inc. Common Stock.